Works matching DE "IPILIMUMAB"

Results: 2440
    1

    Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 490, doi. 10.1159/000541250
    By:
    • LaPelusa, Michael;
    • Chamseddine, Shadi;
    • Tran Cao, Hop Sanderson;
    • Xiao, Lianchun;
    • Hasanov, Elshad;
    • Bhosale, Priya;
    • Amin, Hesham M.;
    • Mohamed, Yehia I.;
    • Gok Yavuz, Betul;
    • Sakr, Yara;
    • Xu, Li;
    • Hu, Ian;
    • Lee, Sunyoung S.;
    • Sakamuri, Divya;
    • Jindal, Sonali;
    • Nguyen, Van;
    • Curran, Michael A.;
    • Sun, Ryan;
    • Rashid, Asif;
    • Duda, Dan Gabriel
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Long-Term Survival in Patients With Advanced Melanoma.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 8, p. e2426641, doi. 10.1001/jamanetworkopen.2024.26641
    By:
    • van Not, Olivier J.;
    • van den Eertwegh, Alfons J. M.;
    • Jalving, Hilde;
    • Bloem, Manja;
    • Haanen, John B.;
    • van Rijn, Rozemarijn S.;
    • Aarts, Maureen J. B.;
    • van den Berkmortel, Franchette W. P. J.;
    • Blank, Christian U.;
    • Boers-Sonderen, Marye J.;
    • de Groot J. W. B., Jan Willem;
    • Hospers, Geke A. P.;
    • Kapiteijn, Ellen;
    • Leeneman, Brenda;
    • D., Piersma;
    • Stevense-den Boer, Marion;
    • van der Veldt, Astrid A. M.;
    • Vreugdenhil G., Gerard;
    • Wouters, Michel W. J. M.;
    • Blokx, Willeke A. M.
    Publication type:
    Article
    17
    18
    19

    Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials.

    Published in:
    Journal of Clinical Medicine, 2018, v. 7, n. 12, p. 542, doi. 10.3390/jcm7120542
    By:
    • Grassadonia, Antonino;
    • Sperduti, Isabella;
    • Vici, Patrizia;
    • Iezzi, Laura;
    • Brocco, Davide;
    • Gamucci, Teresa;
    • Pizzuti, Laura;
    • Maugeri-Saccà, Marcello;
    • Marchetti, Paolo;
    • Cognetti, Gaetana;
    • De Tursi, Michele;
    • Natoli, Clara;
    • Barba, Maddalena;
    • Tinari, Nicola
    Publication type:
    Article
    20
    21
    22
    23
    24

    Diabetes induced by checkpoint inhibition in nonobese diabetic mice can be prevented or reversed by a JAK1/JAK2 inhibitor.

    Published in:
    Clinical & Translational Immunology, 2022, v. 11, n. 11, p. 1, doi. 10.1002/cti2.1425
    By:
    • Ge, Tingting;
    • Phung, Amber‐Lee;
    • Jhala, Gaurang;
    • Trivedi, Prerak;
    • Principe, Nicola;
    • De George, David J;
    • Pappas, Evan G;
    • Litwak, Sara;
    • Sanz‐Villanueva, Laura;
    • Catterall, Tara;
    • Fynch, Stacey;
    • Boon, Louis;
    • Kay, Thomas W;
    • Chee, Jonathan;
    • Krishnamurthy, Balasubramanian;
    • Thomas, Helen E
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Clinical predictors of response to single‑agent immune checkpoint inhibitors in chemotherapy‑pretreated non‑small cell lung cancer.

    Published in:
    Molecular & Clinical Oncology, 2024, v. 20, n. 4, p. N.PAG, doi. 10.3892/mco.2024.2730
    By:
    • Musaelyan, Aram A.;
    • Moiseyenko, Fedor V.;
    • Emileva, Tancholpon E.;
    • Oganesyan, Ani P.;
    • Oganyan, Karina A.;
    • Urtenova, Magaripa A.;
    • Odintsova, Svetlana V.;
    • Chistyakov, Ivan V.;
    • Degtyarev, Alexey M.;
    • Akopov, Andrey L.;
    • Imyanitov, Evgeny N.;
    • Orlov, Sergey V.
    Publication type:
    Article
    48
    49
    50